MONTREAL, March 30 /CNW Telbec/ - Biophage Pharma Inc. (TSX: BUG.V), a
high potential, revenue driven biotechnology company focused on the
development of an integrated approach for the prevention and control of
bacterial infections, announced today its financial results and review of
operating hightlights for the year ended November 30, 2006.
